Product Overview: YOHI-15 INTEX PHARMA
YOHI-15 is a yohimbine hydrochloride research compound manufactured by Intex Pharma, designed for in-vitro laboratory investigations of alpha-2 adrenergic receptor pharmacology. Yohimbine HCl represents a naturally-derived indole alkaloid compound that serves as a selective alpha-2 adrenergic receptor antagonist in experimental systems. Research scientists at Stroid UK Shop study this compound for its ability to modulate sympathetic nervous system pathways and investigate adrenergic receptor mechanisms in controlled laboratory settings. The compound provides researchers with a standardised tool for examining alpha-2 receptor blockade effects on cellular signalling cascades and neurotransmitter release mechanisms.
Laboratory Applications
Research applications for YOHI-15 encompass investigations into sympathetic nervous system modulation, thermogenic pathway analysis, and adrenergic receptor binding studies. Scientists examine this compound alongside other research materials from our other drugs category to evaluate comparative pharmacological profiles and receptor selectivity patterns. Laboratory studies investigate yohimbine’s capacity to antagonise alpha-2 adrenergic receptors in various tissue preparations, analyse its effects on noradrenaline release mechanisms, and examine potential interactions with metabolic signalling pathways. Researchers often compare findings with established compounds like those available in our SARMs collection to evaluate distinct mechanism profiles, or examine synergistic effects when studied alongside materials from our peptides range in comprehensive research protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Product Name | YOHI-15 |
| Manufacturer | Intex Pharma |
| Active Compound | Yohimbine HCl |
| CAS Number | 65-19-0 |
| Molecular Formula | C₂₁H₂₇ClN₂O₃ |
| Molecular Weight | 390.91 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Intended Use | Laboratory research only |
Research Compliance
YOHI-15 is supplied exclusively for in-vitro research purposes and is not intended for human consumption, clinical applications, or therapeutic use. This research compound is designed for qualified laboratory personnel conducting investigations into adrenergic receptor pharmacology, sympathetic nervous system mechanisms, and related biochemical pathways under controlled experimental conditions. Researchers must maintain appropriate laboratory safety protocols and ensure proper storage conditions to preserve compound integrity throughout the duration of their studies.
